🔍 Key Findings
- SVAPs placed in axillary (aSVAP) or femoral/external iliac veins (fSVAP) during limb amputation remained functional in 92.3% and 100% of cases, respectively.
- Complication rates were lower in aSVAP (23.1%) and fSVAP (0%) compared to jSVAP (47.4%), although not statistically significant (P = .12).
- No catastrophic complications occurred with aSVAP or fSVAP; 2 deaths occurred with jSVAP due to port-related issues.
- Infection-related port removal was needed in 1 aSVAP (7.7%) and 2 jSVAPs (10.5%) — no removals were required in fSVAPs.
- Tip placement of the catheter (e.g., right atrium vs. vena cava) did not correlate with complications (P = .66).
- Shorter surgical time likely with aSVAP/fSVAP as they use the same surgical field as the limb amputation.
- Survival time median was similar across groups (jSVAP: 177 days, aSVAP: 125 days, fSVAP: 122 days).
- SVAP implantation during limb amputation offers a practical and safe alternative to separate jugular placement.

